[
  {
    "ts": null,
    "headline": "Does This Valuation Of Boston Scientific Corporation (NYSE:BSX) Imply Investors Are Overpaying?",
    "summary": "Key Insights Boston Scientific's estimated fair value is US$74.57 based on 2 Stage Free Cash Flow to Equity Current...",
    "url": "https://finnhub.io/api/news?id=7ef2d06520b12b04d31ac562212d74ee7de6396fac6774e35f3c1b9810659a8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749985220,
      "headline": "Does This Valuation Of Boston Scientific Corporation (NYSE:BSX) Imply Investors Are Overpaying?",
      "id": 135286159,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Key Insights Boston Scientific's estimated fair value is US$74.57 based on 2 Stage Free Cash Flow to Equity Current...",
      "url": "https://finnhub.io/api/news?id=7ef2d06520b12b04d31ac562212d74ee7de6396fac6774e35f3c1b9810659a8c"
    }
  }
]